List of Excipients in API tobramycin and dexamethasone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tobramycin and dexamethasone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | EDETATE DISODIUM | |
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | HYDROXYETHYL CELLULOSE | |
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | SODIUM CHLORIDE | |
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | SODIUM HYDROXIDE | |
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | SODIUM SULFATE | |
| Alcon Laboratories Inc | TOBRADEX | tobramycin and dexamethasone | 0065-0647 | SULFURIC ACID | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tobramycin and dexamethasone
Detailed excipient profiles for tobramycin and dexamethasone
Excipient focus: BENZALKONIUM CHLORIDE
tobramycin and dexamethasone drug variants containing BENZALKONIUM CHLORIDE
tobramycin and dexamethasone drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: CHLOROBUTANOL
tobramycin and dexamethasone drug variants containing CHLOROBUTANOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
tobramycin and dexamethasone drug variants not containing CHLOROBUTANOL
Excipient focus: EDETATE DISODIUM
tobramycin and dexamethasone drug variants containing EDETATE DISODIUM
tobramycin and dexamethasone drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
tobramycin and dexamethasone drug variants containing HYDROXYETHYL CELLULOSE
tobramycin and dexamethasone drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
tobramycin and dexamethasone drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
tobramycin and dexamethasone drug variants not containing MINERAL OIL
Excipient focus: PETROLATUM
tobramycin and dexamethasone drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
tobramycin and dexamethasone drug variants not containing PETROLATUM
Excipient focus: SODIUM CHLORIDE
tobramycin and dexamethasone drug variants containing SODIUM CHLORIDE
tobramycin and dexamethasone drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
tobramycin and dexamethasone drug variants containing SODIUM HYDROXIDE
tobramycin and dexamethasone drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM SULFATE
tobramycin and dexamethasone drug variants containing SODIUM SULFATE
tobramycin and dexamethasone drug variants not containing SODIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
tobramycin and dexamethasone drug variants containing SULFURIC ACID
tobramycin and dexamethasone drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
tobramycin and dexamethasone drug variants containing TYLOXAPOL
tobramycin and dexamethasone drug variants not containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
tobramycin and dexamethasone drug variants containing WATER
tobramycin and dexamethasone drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin and dexamethasone | 0065-0648 |
| Novartis Pharmaceuticals Corporation | tobramycin and dexamethasone | 0078-0876 |
| Rebel Distributors Corp | tobramycin and dexamethasone | 21695-628 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
